Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Examedi
AddedMar 22, 2024
UpdatedJun 18, 2026
Examedi

Examedi

Series B

Examedi: Your Uber for at-home healthcare and lab tests in Latin America.

HQ
Las Condes, Santiago Metropolitan Region, CL
Founded
2021
Accelerator
Y Combinator logoY CombinatorS21
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize healthcare accessibility in Latin America, Examedi aims to provide convenient and reliable medical services directly to patients' homes. The company offers a marketplace that connects patients with qualified nurses and lab technicians who perform medical lab work and other healthcare services at home. By leveraging technology, Examedi seeks to make healthcare more accessible and efficient, particularly in underserved regions.

Notable investors and affiliated individuals include prominent figures in the healthcare and technology sectors, contributing to the company's rapid growth and credibility. Key achievements include expanding their service coverage across multiple Latin American countries and significantly improving patient satisfaction and healthcare outcomes. Examedi's impact is evident in its ability to reduce barriers to healthcare access, offering a practical solution for patients who require medical attention but face mobility or logistical challenges.

Examedi - Similar Companies

Healthtracka logo

Healthtracka

healthtracka.com

Getlabs logo

Getlabs

My NextDerma logo

My NextDerma

mynextderma.com

Mederva Health logo

Mederva Health

medervahealth.com

LetsGetChecked logo

LetsGetChecked

letsgetchecked.com

Burrito Labs logo

Burrito Labs

burritolabs.co

Instalab logo

Instalab

instalab.com

Clinikally logo

Clinikally

clinikally.com

TravaLab logo

TravaLab

travalab.com

Selia logo

Selia

selia.co

Medically Home logo

Medically Home

Sprinter Health logo

Sprinter Health

sprinterhealth.com

Okani logo

Okani

okani.care

8medical logo

8medical

8medical.co

NovaXS Biotech logo

NovaXS Biotech

novaxs.co

Examedi - Quick Facts

Who are Examedi's competitors?

Companies similar to Examedi include Healthtracka, Getlabs, My NextDerma and Mederva Health.

When was Examedi founded?

Examedi was founded in 2021.

Where is Examedi's headquarters located?

Examedi's headquarters is located in Las Condes, Santiago Metropolitan Region, CL.

How much has Examedi raised to-date?

As of Jul 8, 2022, Examedi has raised a total of $19.9M (USD).

How many employees does Examedi have?

Examedi has 32 employees as of Feb 24, 2024.

Examedi - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Latin America
Model
  • Marketplace
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Healthcare
  • Lab Tests
Tags
  • Healthtech
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 2 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services